Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
Dobryman, Steven
Ocular Hypertension
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression. Front Oncol. 2015; 5:164.
View in:
PubMed
authors with profiles
Ravi Salgia